65
Participants
Start Date
July 6, 2015
Primary Completion Date
June 19, 2019
Study Completion Date
September 14, 2023
Oral Azacitidine
Oral azacitidine (AZA) 100 mg, 150 mg, or 200 mg tablets twice daily (BID) on days 1 to 21 of each 28-day treatment cycle. Participants continued to receive their assigned study treatment unless disease progression, unacceptable toxicity, lost to follow-up or withdrawal by participant occurred.
Durvalumab
Durvalumab 1500 mg by IV infusion on Day 1 of each 28 day treatment cycle.
Hopital Erasme, Brussels
Local Institution - 802, Brussels
Local Institution - 801, Brussels
Universitair Ziekenhuis Brussel, Brussels
Clinique Saint-Pierre, Ottignies
Westmead Hospital, Westmead
Cabrini Hospital, Malvern
Local Institution - 405, Malvern
Local Institution - 400, Clayton
Monash Medical Centre, Clayton
Centre Hospitalier Universitaire de Liege, Liège
Local Institution - 800, Liège
Royal Brisbane and Women's Hospital, Herston
Local Institution - 401, Adelaide
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Hospital Universitari Vall d'Hebron, Barcelona
Icahn School of Medicine at Mount Sinai, New York
Local Institution - 101, New York
Institut Paoli Calmettes, Marseille
Azienda Ospedaliera Santi Antonio Biagio E Cesare Arrigo, Allessandria
Hillman Cancer Institute at UPMC, Pittsburgh
Hospital Virgenes de las Nieves, Granada
Local Institution - 300, Granada
Local Institution - 110, Philadelphia
University of Pennsylvania, Philadelphia
Ospedale San Raffaele S.r.l., Milan
Hospital General Gregorio Maranon, Madrid
Local Institution - 307, Madrid
Hospital Universitario Virgen De La Victoria, Málaga
CHU Purpan, Toulouse
Hospital Central de Asturias, Oviedo
Local Institution - 303, Oviedo
University of Miami Miller School of Medicine, Miami
H Lee Moffitt Cancer Center and Research Institute, Tampa
Local Institution - 104, Tampa
Hospital Universitario de Salamanca, Salamanca
Local Institution - 304, Salamanca
Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi, Bologna
James Graham Brown Cancer Center, Louisville
Local Institution - 103, Louisville
Local Institution - 502, Düsseldorf
Marien Hospital, Düsseldorf
Hospital Universitario Virgen Del Rocio, Seville
Local Institution - 308, Seville
CEIC Hospital Universitario La Fe, Valencia
Azienda Ospedaliero-Universitaria Careggi, Florence
Local Institution - 601, Florence
Local Institution - 116, Iowa City
University of Iowa Hospitals and Clinics, Iowa City
Medical College of Wisconsin, Milwaukee
Local Institution - 111, Chicago
University of Chicago Medicine, Chicago
Hopital Saint-Louis, Paris
Local Institution - 201, Paris
University of Texas- MD Anderson, Houston
Cancer Care Centers of South Texas - HOAST, San Antonio
Universitatsklinikum Freiburg, Freiburg im Breisgau
Medizinische Klinik III Klinikum der Universität München-Großhadern, München
Local Institution - 113, New Haven
Yale University, New Haven
Ingalls Memorial Hospital, Harvey
Local Institution - 109, Harvey
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Local Institution - 102, Hackensack
Local Institution - UNK-004, Hamilton
Local Institution - 500, Dresden
Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden
Universitatsklinikum Halle Saale, Halle
Universitatsklinikum Leipzig, Leipzig
Azienda Ospedaliera Sant Andrea, Roma
Local Institution - 603, Roma
Zaklad Opieki Zdrowotnej MSW z Warminsko-Mazurskim Centrum Onkologii, Olsztyn
Local Institution - 900, Warsaw
MTZ Clinical Research Sp. z o.o., Warsaw
Uniwersytecki Szpital Kliniczny, Wroclaw
Institut Calatà d'Oncologia, L'Hospitalet, Barcelona
Local Institution - 306, Barcelona
Local Institution - 701, Boston
United Lincolnshire Hospitals NHS Trust, Boston
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge
Broomfield Hospital, Chelmsford
Saint James University Hospital, Leeds
King's College HospitalSchool of Medicine, London
Local Institution - 700, London
Hammersmith Hospital, London
University College London, London
Northwick Park Hospital, Middlesex
Southampton General Hospital, Southampton
Lead Sponsor
Celgene
INDUSTRY